Clinical Trials
3 trialsNCT03717038 2019-02-04
Sym004 Versus TAS-102 in Patients With mCRC
Symphogen A/S
Phase 3 Withdrawn
NCT02924233 2017-08-28
Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Symphogen A/S
Phase 1/2 Withdrawn
NCT02965417 2017-02-01
Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients
Symphogen A/S
Phase 2 Withdrawn